The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
CANDEL THERAPEUTICS INC COM 137404109 3,464,035 1,935,215 SH SOLE 1,935,215 0 0
DICE THERAPEUTICS INC COM 23345J104 102,737,575 3,292,871 SH SOLE 3,292,871 0 0
ISOPLEXIS CORP COM 465005106 13,653,223 8,808,531 SH SOLE 8,808,531 0 0
TELESIS BIO INC COM 192003101 11,812,956 9,844,130 SH SOLE 9,844,130 0 0
VIGIL NEUROSCIENCE INC COM 92673K108 52,681,225 4,214,498 SH SOLE 4,214,498 0 0